Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase II Placebo-controlled Study of the Use of Extended-release Methylphenidate or Modafinil for the Treatment of Excessive Daytime Sleepiness in Children Following Cancer Therapy

NCT01348607 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT01348607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01348607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase II Placebo-controlled Study of the Use of Extended-release Methylphenidate or Modafinil for the Treatment of Excessive Daytime Sleepiness in Children Following Cancer Therapy
Lead sponsor
University of South Florida
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2010
Completion date
December 31, 2012
Enrollment
1 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system tumor, pediatric, fatigue, specific disorders of sleep